Pharmaceuticals in Canada: ISIC 2423

Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Product coverage: Active Substances and Basic Pharmaceutical Products, Medicaments, Vaccines and Other Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Pharmaceuticals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


PHARMACEUTICALS IN CANADA: ISIC 2423
Euromonitor International
December 2017

LIST OF CONTENTS AND TABLES

Headlines
Prospects
Overseas Demand for Canadas Pharmaceuticals Supports Industrys Performance
Domestic Sales Growth To Be Supported by Growing Use of High-cost Speciality Drugs
Demand in Domestic Market Set To Be Ensured by Rapidly Ageing Population
Competitive Landscape
Canadas Government Continues To Provide Support for Innovative Small and Medium-sized Drug Producers
Industry Continues To Strengthen Its Position in the Global Generics and Biosimilar Market
Faced With Massive Debt, Canadian Pharma Giant Valeant Disinvests
Industry Overview
Table 1 Key Industry Indicators 2011-2016
Table 2 Key Industry Indicators: Annual Growth 2012-2016
Chart 1 Production vs Nominal GDP 2001-2021
Chart 2 Producer Volume Index vs Producer Price Index 2001-2016
Industry Sectors
Table 3 Production by Sector: Value 2011-2016
Table 4 Production by Sector: Annual Growth 2012-2016
Table 5 Production by Sector: Share of Total 2011-2016
Chart 3 Industry Sectors Growth Indices 2001-2021
Firmographics
Table 6 Number of Companies by Employment Size 2011-2016
Table 7 Number of Companies by Employment Size: Annual Growth 2012-2016
Table 8 Number of Companies by Employment Size: Share of Total 2011-2016
Table 9 Production by Employment Size 2011-2016
Table 10 Production by Employment Size: Annual Growth 2012-2016
Table 11 Production by Employment Size: Share of Total 2011-2016
Table 12 Industry Leaders: Company Production Shares in 2016
Import and Export
Table 13 Import and Export 2011-2016
Table 14 Export Destinations 2011-2016
Table 15 Importing Countries 2011-2016
Chart 4 Import vs Export Growth 2001-2016
Market and Buyers
Table 16 Key Market Indicators 2011-2016
Table 17 Key Market Indicators: Annual Growth 2012-2016
Households
Table 18 Households: Key Statistics 2011-2016
Chart 5 Household Expenditure on Pharmaceuticals vs GDP 2001-2021
Chart 6 Household Expenditure on Pharmaceuticals vs Population 2001-2021
Suppliers
Table 19 Supply Structure 2011-2016
Table 20 Supply Structure: Annual Growth 2012-2016
Table 21 Supply Structure:Share of Total 2011-2016
Labour Costs
Table 22 Key Statistics 2011-2016
Chart 7 Number of Employees vs Average Salary 2001-2016
Chart 8 Output per Employee vs Average Salary 2001-2016
Industry Attractiveness Index
Table 23 Attractiveness Index Composition
Chart 9 Attractiveness Index of Pharmaceuticals Among Other Canada Industries
Chart 10 Binary Diagram of Attractiveness Index
Attractiveness Index: Explanation
Future Outlook
Table 24 Forecasts 2017-2022
Definitions
Pharmaceuticals













Ophthalmology Drugs Global Market Forecast To 2022 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy) Covering: Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. This

USD 4000 View Report

Ophthalmology Drugs Global Market Forecast To 2022 Including: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy) Covering: Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. This

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available